This is a high-level medical text on the advantages and disadvantages of the newest low-dose oral contraceptives. The contributors are leading investigators in the development of new contraceptives whose four main chapters describe the latest clinical results and scientific studies analyzing the efficacy, cycle control, and tolerability of low-dose pills combining ethinylestradiol and gestodene or ethinylestradiol and desogestrel. The book also contains a chapter on the influence of low-dose oral contraceptives on lipid and carbohydrate metabolism and hemostasis.